In the U.S., both Jardiance and Tradjenta are once-daily tablets used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. Jardiance is also approved to reduce the risk of ...
The European Commission has approved JENTADUETO for use alongside diet and exercise to improve glycemic control in adults with type 2 diabetes who are inadequately controlled on their maximally ...
Mobile and smart devices like tablets have found their place in classrooms and learning facilities where they are put in use to teach children and youths. However, there is another set of demographics ...
RIDGEFIELD, Conn., and INDIANAPOLIS, March 23, 2015 /PRNewswire/ -- Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading ...
The U.S. Food and Drug Administration has approved a once-a-day pill for treating type 2 diabetes from Ridgefield-based Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Co. of Indianapolis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results